Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

BioNTech SE (22UAy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
80.10 -2.20    -2.67%
03:15:01 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US09075V1026 
S/N:  A2PSR2
  • Volume: 0
  • Bid/Ask: 80.10 / 82.00
  • Day's Range: 80.10 - 80.10
BioNTech 80.10 -2.20 -2.67%

22UAy Interactive Chart

 
Get instant access to a free live interactive chart for the BioNTech SE stock. You have the option to change the appearance of the charts by varying the time scale, chart type, zooming in to different sections and adding new studies or indicators such as RSI, MACD, EMA, Bollinger Bands, Fibonacci retracements and many more. You can save your BioNTech stock studies and create your own systems as well as having the option to set the colors of each object on the chart.
Sign In / Free Sign Up now to save your chart settings.
press ESC to exit fullscreen mode
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BNTX Comments

Write your thoughts about Biontech SE
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Besim Ersan
Besim Ersan Apr 11, 2024 2:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news from anti-cancer works?..
Jeromy Pow
Jeromy Pow Sep 29, 2023 1:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hope BNTX will bring their anti-cancer pipeline of the future forward so this will go to moon again and beyond! I especially love the fact that they are developing something against lung cancer!
TheGlobe Trade
TheGlobe Trade Jun 27, 2023 3:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
300% Gain from here Gauranteed
TheGlobe Trade
TheGlobe Trade Apr 27, 2023 9:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you MM
TheGlobe Trade
TheGlobe Trade Apr 24, 2023 7:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strong Buy. This is a steal!
Donavan Allen
Donavan Allen Mar 27, 2023 7:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How about those earnings?! 👀
Carlos GV
Carlos GV Feb 24, 2023 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sold this trash... bye bye
Jay Ow
Jay Ow Dec 07, 2022 6:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
who want buy this can you tell me. So many court is coming. They will must pay a lot for deaths. Full twitter so whole world know
Alper Drn
Alper Drn Dec 07, 2022 6:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will buy more..
cc cc
cc cc Dec 07, 2022 6:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They cant be sued. They had all emergency approval, meaning all goverments waived the right to sue. That was a free lunch for these companies...you have to sue the governments
Ying Yu
Ying Yu Nov 10, 2022 4:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The mRNA vaccine looks like a joke in the vaccine history. It couldn't stop COVID infection and spreading. Biden, Fauci, the head of CDC and The CEO of Pfizer were infected COVID virus after they got 4 shots of mRNA vaccine. Does mRNA vaccine can generate enough folded spike protein as antigen for Antigen presenting cells? Who knows? mRNA vaccine looks like generating shot term nonspecific immune response by its longer RNA chain.
murat ribar
murat ribar Nov 10, 2022 4:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You mean China is a big performer. Funny.
Jack Black
Jack Black Sep 14, 2022 5:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone can recommend me some books to improve my operations? In particular on how to manage my capital. Thank you
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email